Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $52.89, for a total value of $105,780.00. Following the completion of the sale, the director now directly owns 16,618 shares in the company, valued at $878,926.02. This represents a 10.74% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Kira Scherer Wampler also recently made the following trade(s):
- On Monday, June 2nd, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $52.89, for a total value of $105,780.00.
- On Thursday, May 1st, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $56.93, for a total value of $113,860.00.
Doximity Trading Up 2.6%
NASDAQ:DOCS traded up $1.49 during mid-day trading on Friday, hitting $58.83. The company had a trading volume of 2,014,061 shares, compared to its average volume of 2,129,029. The business has a fifty day simple moving average of $54.72 and a 200-day simple moving average of $58.16. Doximity, Inc. has a 1 year low of $25.00 and a 1 year high of $85.21. The firm has a market capitalization of $11.05 billion, a price-to-earnings ratio of 58.83, a PEG ratio of 4.10 and a beta of 1.32.
Doximity (NASDAQ:DOCS - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same quarter last year, the business earned $0.25 EPS. The business's quarterly revenue was up 17.1% compared to the same quarter last year. As a group, research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the company. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of Doximity in a research note on Friday, February 7th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the company a "neutral" rating in a research note on Wednesday, May 21st. Morgan Stanley reduced their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Needham & Company LLC reduced their target price on Doximity from $82.00 to $67.00 and set a "buy" rating on the stock in a research note on Friday, May 16th. Finally, Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and upped their target price for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $62.84.
Get Our Latest Stock Analysis on Doximity
Institutional Trading of Doximity
A number of hedge funds and other institutional investors have recently modified their holdings of DOCS. Shaker Investments LLC OH acquired a new position in Doximity in the fourth quarter worth about $559,000. Principal Financial Group Inc. grew its stake in Doximity by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock worth $15,695,000 after purchasing an additional 4,282 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new position in Doximity in the fourth quarter worth about $362,000. Stratos Wealth Partners LTD. acquired a new position in Doximity in the fourth quarter worth about $203,000. Finally, Wells Fargo & Company MN grew its stake in Doximity by 3.3% in the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock worth $19,698,000 after purchasing an additional 11,811 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.
About Doximity
(
Get Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.